RHOPRESSA® (netarsudil ophthalmic solution) 0.02% is a prescription medicine to reduce high eye pressure (intraocular pressure, or IOP) in patients with open-angle glaucoma or ocular hypertension.

What is Rhopressa? Netarsudil lowers pressure inside the eye by increasing the amount of fluid that drains from the eye. Rhopressa (for the eyes) is used to treat open-angle glaucoma or other causes of high pressure inside the eye.

Rhopressa ® (netarsudil ophthalmic solution) 0.02% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Jul 7, 2024 · Rhopressa, also known by its generic name, netarsudil, is an eye drop medication used to lower eye pressure in people with glaucoma or ocular hypertension. It received FDA approval in December 2017 and belongs to a newer class of medications called ROCK (rho kinase) inhibitors.

RHOPRESSA® (netarsudil ophthalmic solution) 0.02% is a Rho kinase inhibitor indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular...

Aug 31, 2018 · Rhopressa: First ROCK Inhibitor. Like Vyzulta, Rhopressa is a once-daily eyedrop. However, as a Rho kinase (ROCK) inhibitor, it represents the first new class of glaucoma drugs in more than 20 years. Triple mechanism of action. Rhopressa possesses 3 different mechanisms of action in a single agent, said Dr. Aref.

Learn about the side effects of Rhopressa (netarsudil), from common to rare, for consumers and healthcare professionals.

Aug 25, 2024 · Rhopressa is a medicine classified as a Rho kinase inhibitor. People with glaucoma or ocular hypertension have high intraocular pressure (IOP), or high pressure inside the eye. Having high...

Sep 30, 2024 · RHOPRESSA ® is a Rho kinase inhibitor indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. (1) One drop into the affected eye (s) once daily in the evening. (2) Ophthalmic solution containing netarsudil 0.02%. (3) None. (4)

Netarsudil, sold under the brand name Rhopressa among others, is a medication for the treatment of glaucoma. [1] [2] [3] In the United States, in December 2017, the Food and Drug Administration (FDA) approved a 0.02% ophthalmic solution for the lowering of elevated intraocular pressure in people with open-angle glaucoma or ocular hypertension.